2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
Canada
Patent Litigation (Generic)
| Patent Litigation (Generic) — Highly Recommended |
|---|
| Aitken Klee |
| Goodmans |
| Osler Hoskin & Harcourt |
| Patent Litigation (Generic) — Recommended |
|---|
| Bennett Jones |
| Fineberg Ramamoorthy |
| Sprigings |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Brodkin, Andrew | Canada | Financial & Corporate | Toronto |
| Radomski, Harry | Canada | Intellectual Property | Toronto |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Canada
Goodmans
Goodmans has a strong reputation in life sciences for its practice focused on patent litigation for generic drug makers. "They have been the leader in generics," a peer says. Another peer calls the firm a "force to be reckoned with." The group frequently acts as counsel to generic powerhouse Apotex in patent disputes. Goodmans was shortlisted by LMG Life Sciences for the Canadian Patent Contentious Firm of the Year award in 2019.
Andrew Brodkin is a leading lawyer for patent litigation, described by a peer as "top-of-the-heap." He is experienced in matters before the Federal Court and Supreme Court of Canada. Brodkin was recently shortlisted for the Canadian Patent Litigation Attorney of the Year award.
An up-and-comer at the firm Ben Hackett, who has amassed significant experience representing Apotex in patent infringement matters.